4//SEC Filing
Shafer Bradford J 4
Accession 0001179110-18-011003
CIK 0001583107other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 6:24 PM ET
Size
4.9 KB
Accession
0001179110-18-011003
Insider Transaction Report
Form 4
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Transactions
- Sale
Ordinary Shares
2018-08-27$27.71/sh−7,119$197,282→ 84,000 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices from $27.65 to $27.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001302448
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 6:24 PM ET
- Size
- 4.9 KB